Publications (19) Publications in which a researcher has participated

filter_list Hepatology

2024

  1. ApaI Polymorphism in the Vitamin D Receptor Gene Decreases the Risk of Perianal Fistulas in Crohn’s Disease

    Nutrients , Vol. 16, Núm. 20

  2. Interference with mitochondrial function as part of the antifibrogenic effect of Rilpivirine: A step towards novel targets in hepatic stellate cell activation

    Biomedicine and Pharmacotherapy, Vol. 178

  3. Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia

  4. Rilpivirine Activates STAT1 in Non-Parenchymal Cells to Regulate Liver Injury in People Living with HIV and MASLD

    Biomedicines, Vol. 12, Núm. 7

2023

  1. Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease

    Biomedicine and Pharmacotherapy, Vol. 167

2022

  1. Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is less

    Cell Death and Disease, Vol. 13, Núm. 4

  2. Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis

    American Journal of Pathology, Vol. 192, Núm. 1, pp. 87-103

  3. Macrophages Modulate Hepatic Injury Involving NLRP3 Inflammasome: The Example of Efavirenz

    Biomedicines, Vol. 10, Núm. 1

  4. SUCNR1 Mediates the Priming Step of the Inflammasome in Intestinal Epithelial Cells: Relevance in Ulcerative Colitis

    Biomedicines, Vol. 10, Núm. 3

2021

  1. NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved

    Cells, Vol. 10, Núm. 7

2020

  1. Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells

    Gut, Vol. 69, Núm. 5, pp. 920-932

  2. Succinate Activates EMT in Intestinal Epithelial Cells through SUCNR1: A Novel Protagonist in Fistula Development

    Cells, Vol. 9, Núm. 5

2019

  1. Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis

    Autophagy, Vol. 15, Núm. 11, pp. 1954-1969

2018

  1. Fasting Imparts a Switch to Alternative Daily Pathways in Liver and Muscle

    Cell Reports, Vol. 25, Núm. 12, pp. 3299-3314.e6

  2. Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice

    Gastroenterology, Vol. 155, Núm. 3, pp. 865-879.e12

2017

  1. Activation of the c-Jun N-terminal kinase pathway aggravates proteotoxicity of hepatic mutant Z alpha1-antitrypsin

    Hepatology, Vol. 65, Núm. 6, pp. 1865-1874

  2. Enhancement of hepatic autophagy increases ureagenesis and protects against hyperammonemia

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Núm. 2, pp. 391-396

2016

  1. Endoplasmic reticulum and mitochondria: Independent roles and crosstalk in fatty liver diseases and hepatic inflammation

    Current Pharmaceutical Design, Vol. 22, Núm. 18, pp. 2607-2618

  2. Nuevas perspectivas en el tratamiento farmacológico de la Hepatitis C

    Revista Habanera de Ciencias Medicas, Vol. 15, Núm. 5, pp. 724-743